Publications by authors named "Gamze Beydagi"

Claim this Profile
[
[177Lu]Lu-FAP-2286 therapy in ovarian neuroendocrine carcinoma: a promising theranostic approach.
Nalan Alan-Selcuk, Kaan Akcay, Gamze Beydagi, Resit Akyel, Turkay Toklu

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Istanbul PSMA PET/CT criteria (IPPC): an imaging-based approach to patient selection for active surveillance.
Levent Kabasakal, Kaan Akçay, Alan Nalan Selçuk, Gamze Beydağı, Elife Akgün

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of [⁶⁸Ga]Ga-FAP-2286 PET/CT in the evaluation of treatment response in gastrointestinal system malignancies.
Nalan Alan Selcuk, Gamze Beydagi, Kaan Akcay, Ayşegul Gormez, Turkay Toklu

Eur J Nucl Med Mol Imaging· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Integrin Imaging with [Ga]Ga-Trivehexin PET/CT for a Patient with Breast Cancer and Neuroendocrine Neoplasm: A Case of Both (F)FDG PET/CT and [Ga]Ga-DOTATATE Positive but Integrin αvβ6 Negative Lesion on [Ga]Ga-Trivehexin PET.
Gamze Beydağı, Nalan Alan Selçuk, Kaan Akçay, Onur Yaprak, Murat Kalaycı

Mol Imaging Radionucl Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Accuracy and Reliability of PRIMARY Scoring Using Delayed [Ga] Ga-PSMA PET/CT Imaging.
Kaan Akçay, Gamze Beydağı, Onur Erdem Şahin, Reşit Akyel, Elife Akgün

Mol Imaging Radionucl Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal F-FDG PET/CT Findings.
Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, Emre Demirci, Ayşegül Görmez

Mol Imaging Radionucl Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer.
Oğuzcan Kınıkoğlu, Bala Başak Öven, Serkan Çelik, Nalan Alan Selçuk, Gamze Beydağı

J Clin Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revision of the Histopathological Examination Following Ga-DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis.
Nalan Alan Selçuk, Kaan Akçay, Gamze Beydağı, Ömer Sönmez, Serkan Çelik

Mol Imaging Radionucl Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of clinically significant prostate cancer by [ Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.
Kaan Akcay, Ali Kibar, Onur Erdem Sahin, Muhammet Demirbilek, Gamze Beydagi

Eur J Nucl Med Mol Imaging· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Experience with [Ac]Ac-PSMA Treatment in Patients with [Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer.
Nalan Alan-Selcuk, Gamze Beydagi, Emre Demirci, Meltem Ocak, Serkan Celik

J Nucl Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Findings on the Use of [Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors.
Emre Demirci, Nalan Alan Selçuk, Gamze Beydağı, Meltem Ocak, Türkay Toklu

Mol Imaging Radionucl Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis